Allele Communications

Investor Relations & Capital Markets Optimization | Scalable Investor Acquisition & Digital Outreach | SEC & FINRA Compliant | Public & Private Companies

[Allele Communications @AlleleComms]

We leverage our life science and medical sector expertise to create communications impact – for your organization and patients in need

Let's make an impact together!

#Allele #Communications #LifeSciences #Media #SocialMedia #Science #DrugDiscovery #Patients #runboyrun

[Allele Communications @AlleleComms]

@TeamYouTube Thank you @TeamYouTube - we've tried those steps several times. Could you transition us to a DM so we can be more open about the account? We know the business email it's linked with and have access to that account. The issue is the phone number is a landline and can't get code.

[Allele Communications @AlleleComms]

@TeamYouTube We are a business trying to recover our official YT channel. We have access to the primary email, but the recovery phone is a landline. Can you help us verify via email instead?

[Allele Communications @AlleleComms]

The Allele Communications team came out in full force this past weekend for the Victory Over Cancer 5K!

We were thrilled to take part in this race for a great cause, and we can't wait to participate next year.

#V5k #VictoryOverCancer

[ABVC BioPharma @ABVCBioPharma]

Press Release: ABVC Corporate Update and CEO's Letter to Shareholders

https://t.co/HViJNnQ4ji

$ABVC #shareholders #investment #nasdaq #science #drugdevelopment #drugresearch

[Allele Capital @allele_capital]

Every week we go over the latest in Biotech news with our Biotech Weekly report
Read the full report here: https://t.co/TzVjf8pQY3
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research

[Genelux @Genelux_Corp]

Genelux Strengthens Leadership Team With Key New Hires.
Read more here: https://t.co/xwHCh7fzqw

$GNLX #biotech #stage4needsmore

[Genelux @Genelux_Corp]

Historical data in 4th line and beyond shows a median overall survival of only 9.8 months on a median fifth line of treatment, while Olvi-Vec Phase 2 patients achieved a mOS of 15.7 mos.
#stage4needsmore #drugdevelopment #biotech #finance

[Allele Capital @allele_capital]

This weeks Biotech Weekly report is out! Read the full report here: https://t.co/TzVjf8pQY3
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science #RandD #research

[Allele Capital @allele_capital]

Check out 3 Allele clients on @BioPharmaDive most recent IPO's
Great to see Genelux standing out from the pack!
$GNLX $COYA $GDTC
#capitalmarkets #analytics #stocks #biotech #pharma #nasdaq #science
#RandD #research #biotech #biopharma

[Allele Communications @AlleleComms]

@Genelux_Corp Fantastic!

[Allele Capital @allele_capital]

This weeks Biotech Weekly report is out! Read the full report here: https://t.co/TzVjf8pQY3
#capitalmarkets #analytics #stocks #biotech
#pharma #nasdaq #science
#RandD #research

[Allele Communications @AlleleComms]

Have a happy and safe 4th of July, from all of us at Allele Communications.

[Allele Capital @allele_capital]

This weeks Biotech Weekly report is out! We are pleased to see our client @Genelux_Corp as the top performing Biotech IPO so far this year.
read the full report here https://t.co/TzVjf8pQY3
#capitalmarkets #analytics #stocks #biotech
#pharma #nasdaq #science
#RandD #research

[ABVC BioPharma @ABVCBioPharma]

ABVC is currently in clinical trials of several treatments with exciting herbal medicines, that go under US FDA standards and trials.

[Allele Communications @AlleleComms]

We have been able to show exceptional organic growth for our clients on their social media platforms. This growth is a result on creating high-quality, relevant content that resonates with target audiences.
#digitalmarketing #marketing #socialmedia

[LyGenesis @LyGenesis_Inc]

Join @mattpillar at @BioProcessOL for an in-depth conversation with Dr. Michael Hufford, CEO of @LyGenesis as he speaks on the evolving industry of regenerative medicine and the advancements LyGenesis is making. Check out the video: https://t.co/hQ0y3brVws
#CellTx #Bioreactor

[Nasdaq Exchange @NasdaqExchange]

.@Genelux_Corp is redefining immuno-oncology.

$GNLX is a late clinical-stage biotechnology company focused on improving the lives of patients affected by difficult-to-treat solid tumors. #NasdaqListed #CancerResearch

[Genelux @Genelux_Corp]

We are thrilled to announce that we will be ringing the opening bell at Nasdaq on March 29th 2023! #nasdaq #genelux #openingbell
https://t.co/d3Y0QusDIn

[LyGenesis @LyGenesis_Inc]

LyGenesis is currently enrolling patients with End Stage Liver Disease in a Phase 2 clinical study (NCT04496479). Visit our website for more information: https://t.co/hGHfuo4Oxy.
#LymphNode #DrugDiscovery #EndStageLiverDisease #Biotech #OrganRegeneration #CellTherapy #Allogeneic

[Allele Communications @AlleleComms]

Welcoming Amazon to Pharma!
What does this mean for consumers, patients, doctors, and Pharma? Swipe and read more!

For more trending stories follow Allele Comms.

#Science #News #Biotech #Marketing #Communications #BioInformatics #Amazon
#Biotech #Allele #Pharma #DrugDiscovery